Through this process, Merck discovered that Vioxx did indeed carry a small but unacceptable risk of cardiac problems when used for longer than 18 months.
Did the 20 million Americans who used the drug since its launch in 1999 really have to spend that extra money and, as it turns out, incur a slight extra risk?
Vioxx was approved after trials held under the auspices of the Food and Drug Administration showed it to be effective (which it was).
Vioxx is a new-generation painkiller, one of several that are (or were) prescribed instead of aspirin or other over-the-counter drugs.
